Recurrent Kawasaki disease: USA and Japan

Pediatrics International

Volumn 57, Issue 6, 2015, Pages 1116-1120

  Maddox, Ryan A ^a   Holman, Robert C ^a   Uehara, Ritei ^e   Callinan, Laura S ^a   Guest, Jodie L ^b,c   Schonberger, Lawrence B ^a   Nakamura, Yosikazu ^d   Yashiro, Mayumi ^d   Belay, Ermias D ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ATLANTA VA MEDICAL CENTER   (United States)

^d JICHI MEDICAL UNIVERSITY   (Japan)

^e Utsunomiya City Public Health Center   (Japan)

Author keywords

epidemiology; Kawasaki disease; Kawasaki syndrome; mucocutaneous lymph node syndrome; recurrence

Indexed keywords

IMMUNOGLOBULIN;

ARTICLE; CERVICAL LYMPHADENOPATHY; CHILD; COLOMBIA; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HUMAN; JAPAN; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PACIFIC ISLANDER; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; UNITED STATES; CLINICAL TRIAL; HEALTH SURVEY; INFANT; MORBIDITY; MULTICENTER STUDY; NEWBORN; PRESCHOOL CHILD; RETROSPECTIVE STUDY; TRENDS;

CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; JAPAN; MALE; MORBIDITY; MUCOCUTANEOUS LYMPH NODE SYNDROME; POPULATION SURVEILLANCE; RECURRENCE; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84983189618     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/ped.12733     Document Type: Article

References (27)

1. Belay ED, Holman RC, Clarke MJ, et al., The incidence of Kawasaki syndrome in West Coast health maintenance organizations. Pediatr. Infect. Dis. J. 2000; 19: 828-32.
2. Belay ED, Maddox RA, Holman RC, Curns AT, Ballah K, Schonberger LB,. Kawasaki syndrome and risk factors for coronary artery abnormalities, United States, 1994-2003. Pediatr. Infect. Dis. J. 2006; 25: 245-9.
3. Holman RC, Curns AT, Belay ED, Steiner CA, Schonberger LB,. Kawasaki syndrome hospitalizations in the United States, 1997 and 2000. Pediatrics 2003; 112: 495-501.
4. Newburger JW, Takahashi M, Gerber MA, et al., Diagnosis, treatment, and long-term management of Kawasaki disease: A statement for health professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004; 110: 2747-71.
5. Nakamura Y, Yanagawa H,. The worldwide epidemiology of Kawasaki disease. Prog. Pediatr. Cardiol. 2004; 19: 99-108.
6. Uehara R, Belay ED, Maddox RA, et al., Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan. Pediatr. Infect. Dis. J. 2008; 27: 155-60.
7. Nakamura Y, Yashiro M, Uehara R, et al., Epidemiologic features of Kawasaki disease in Japan: Results of the 2009-2010 nationwide survey. J. Epidemiol. 2012; 22: 216-21.
8. Khan AS, Holman RC, Clarke MJ, Vernon LL, Gyurik TP, Schonberger LB,. Kawasaki syndrome surveillance United States, 1991-1993. In:, Kato H, (ed). Kawasaki Disease. Elsevier Science, The Netherlands, 1995.
9. Gibbons RV, Parashar UD, Holman RC, et al., An evaluation of hospitalizations for Kawasaki syndrome in Georgia. Arch. Pediatr. Adolesc. Med. 2002; 156: 492-6.
10. Holman RC, Curns AT, Belay ED, et al., Kawasaki syndrome in Hawaii. Pediatr. Infect. Dis. J. 2005; 24: 429-33.
11. Holman RC, Belay ED, Christensen KY, Folkema AM, Steiner CA, Schonberger LB,. Hospitalizations for Kawasaki syndrome among children in the United States, 1997-2007. Pediatr. Infect. Dis. J. 2010; 29: 483-8.
12. Yanagawa H, Nakamura Y, Yashiro M, Uehara R, Oki I, Kayaba K,. Incidence of Kawasaki disease in Japan: The nationwide surveys of 1999-2002. Pediatr. Int. 2006; 48: 356-61.
13. Nakamura Y, Yashiro M, Uehara R, Oki I, Kayaba K, Yanagawa H,. Increasing incidence of Kawasaki disease in Japan: Nationwide survey. Pediatr. Int. 2008; 50: 287-90.
14. Nakamura Y, Yashiro M, Uehara R, Oki I, Watanabe M, Yanagawa H,. Epidemiologic features of Kawasaki disease in Japan: Results from the nationwide survey in 2005-2006. J. Epidemiol. 2008; 18: 167-72.
15. Holman RC, Christensen KY, Belay ED, et al., Racial/ethnic differences in the incidence of Kawasaki syndrome among children in Hawaii. Hawaii Med. J. 2010; 69: 194-7.
16. Nakamura Y, Hirose K, Yanagawa H, Kato H, Kawasaki T,. Incidence rate of recurrent Kawasaki disease in Japan. Acta Paediatr. 1994; 83: 1061-4.
17. Hirata S, Nakamura Y, Yanagawa H,. Incidence rate of recurrent Kawasaki disease and related risk factors: From the results of nationwide surveys of Kawasaki disease in Japan. Acta Paediatr. 2001; 90: 40-44.
18. Joffe A, Kabani A, Jadavji T,. Atypical and complicated Kawasaki disease in infants. Do we need criteria? West. J. Med. 1995; 162: 322-7.
19. Witt MT, Minich LL, Bohnsack JF, Young PC,. Kawasaki disease: More patients are being diagnosed who do not meet American Heart Association criteria. Pediatrics 1999; 104 (1): e10.
20. Nakamura Y, Yanagawa H,. A case-control study of recurrent Kawasaki disease using the database of the nationwide surveys in Japan. Eur. J. Pediatr. 1996; 155: 303-7.
21. Nakamura Y, Oki I, Tanihara S, Ojima T, Yanagawa H,. Cardiac sequelae in recurrent cases of Kawasaki disease: A comparison between the initial episode of the disease and a recurrence in the same patients. Pediatrics 1998; 102 (6): e66.
22. Zou LX, Gong FQ,. Clinical features of recurrent Kawasaki disease in 20 children. Zhongguo Dang Dai Er Ke Za Zhi 2008; 10: 617-19.
23. Nakada T,. Clinical features of patients with recurrent Kawasaki disease. Nippon Rinsho 2008; 66: 296-300.
24. Vargo TA, Huhta JC, Moore WH, Person DA, Edwards MS,. Recurrent Kawasaki disease. Pediatr. Cardiol. 1986; 6: 199-202.
25. Centers for Disease Control and Prevention. Kawasaki syndrome. [Cited 17 February 2012]. Available from http://www.cdc.gov/kawasaki/.
26. Sonobe T, Kiyosawa N, Tsuchiya K, et al., Presence of coronary artery abnormality in incomplete Kawasaki disease. Pediatr. Int. 2007; 49: 421-6.
27. Kobayashi T, Saji T, Otani T, et al., for the RAISE study group investigators. Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): A randomised, open-label, blinded-endpoints trial. Lancet 2012; 379: 1613-20.